$NX

Quanex Building Products CORP

CIK:0001423221|SEC Filings

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Income Statement [Abstract]
Net sales	$ 501,845	$ 495,273	$ 1,373,301	$ 1,347,795
Cost and expenses:
Cost of sales (excluding depreciation and amortization)	360,380	357,305	1,015,517	986,129
Selling, general and administrative	70,837	71,270	216,695	208,253
Restructuring charges	0	1,367	0	10,207
Depreciation and amortization	24,138	33,882	73,037	77,814
Goodwill impairment charges	0	302,284	0	302,284
Operating income (loss)	46,490	(270,835)	68,052	(236,892)
Non-operating income (expense):
Interest expense	(11,978)	(14,218)	(36,387)	(42,344)
Other, net	(93)	855	5,972	1,925
Income (loss) before income taxes	34,419	(284,198)	37,637	(277,311)
Income tax (expense) benefit	(7,915)	8,191	(11,854)	6,934
Net income (loss)	$ 26,504	$ (276,007)	$ 25,783	$ (270,377)
Basic and diluted earnings (loss) per common share	$ 0.58	$ (6.04)	$ 0.57	$ (5.83)
Diluted earnings (loss) per common share	$ 0.58	$ (6.04)	$ 0.57	$ (5.83)
Weighted-average common shares outstanding:
Basic (in shares)	45,461	45,691	45,466	46,395
Diluted (in shares)	45,648	45,691	45,607	46,395
Cash dividends per share (in usd per share)	$ 0.08	$ 0.08	$ 0.24	$ 0.24

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
Operating activities:
Net income (loss)	$ 25,783	$ (270,377)
Adjustments to reconcile net income (loss) to cash used for operating activities:
Depreciation and amortization	73,037	77,814
Stock-based compensation	3,617	2,762
Deferred income tax	664	(26,440)
Goodwill impairment charges	0	302,284
Other, net	4,640	9,203
Changes in assets and liabilities:
Increase in accounts receivable	(8,685)	(1,727)
(Increase) decrease in inventory	(21,129)	5,261
Increase in other current assets	(4,430)	(7,228)
(Decrease) increase in accounts payable	(2,365)	144
Decrease in accrued liabilities	(7,601)	(9,725)
Change in income taxes	(6,629)	(21)
Other, net	366	(5,307)
Cash provided by operating activities	57,268	76,643
Investing activities:
Capital expenditures	(33,066)	(40,996)
Proceeds from disposition of capital assets	62	361
Cash used for investing activities	(33,004)	(40,635)
Financing activities:
Borrowings under credit facility	141,500	170,000
Repayments of credit facility borrowings	(164,250)	(213,750)
Repayments of other long-term debt	(3,316)	(1,962)
Common stock dividends paid	(10,916)	(11,233)
Purchase of treasury stock	(1,707)	(29,248)
Proceeds from (Payment for) Other Financing Activity	(704)	(1,186)
Cash used for financing activities	(39,393)	(87,379)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,228	16,302
Decrease in cash, cash equivalents and restricted cash	(13,901)	(35,069)
Cash, cash equivalents and restricted cash at beginning of period	78,118	102,995
Cash, cash equivalents and restricted cash at end of period	$ 64,217	$ 67,926

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 31, 2026	Oct. 31, 2025
Current assets:
Cash and cash equivalents	$ 62,094	$ 76,018
Restricted cash	2,123	2,100
Accounts receivable, net of allowance for credit losses of $2,618 and $2,039	214,768	205,384
Inventories	276,396	254,122
Income taxes receivable	5,603	0
Prepaid Expense	37,452	32,387
Prepaid assets	3,847	3,764
Total current assets	602,283	573,775
Property, plant and equipment, net of accumulated depreciation of $455,986 and $414,809	394,021	411,591
Operating lease right-of-use assets	171,552	154,866
Deferred income tax assets	300	2,706
Goodwill	273,765	271,346
Intangible assets, net	522,218	549,137
Other noncurrent assets	4,552	4,812
Total assets	1,968,691	1,968,233
Current liabilities:
Accounts payable	127,030	131,307
Accrued liabilities	88,209	95,155
Income taxes payable	9,300	12,076
Current maturities of long-term debt	26,551	27,561
Current operating lease liabilities	18,822	15,446
Total current liabilities	269,912	281,545
Long-term debt	636,814	665,268
Noncurrent operating lease liabilities	160,290	145,459
Deferred income tax liabilities	137,766	135,993
Other noncurrent liabilities	18,465	13,789
Total liabilities	1,223,247	1,242,054
Commitments and contingencies
Stockholders’ equity:
Preferred stock, no par value, shares authorized 1,000,000; issued and outstanding - none	0	0
Common stock, $0.01 par value, shares authorized 125,000,000; issued 51,159,137 and 51,211,469, respectively; outstanding 45,823,208 and 45,674,726, respectively	512	512
Additional paid-in-capital	697,598	700,029
Retained earnings	179,472	164,710
Accumulated other comprehensive loss	(32,142)	(35,439)
Less: Treasury stock at cost, 5,335,929 and 5,536,743 shares, respectively	(99,996)	(103,633)
Total stockholders’ equity	745,444	726,179
Total liabilities and stockholders' equity	$ 1,968,691	$ 1,968,233